These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2279212)

  • 1. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone.
    Loimer N; Schmid R; Lenz K; Presslich O; Grünberger J
    Br J Psychiatry; 1990 Nov; 157():748-52. PubMed ID: 2279212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar efficacy of abrupt and gradual opiate detoxification.
    Loimer N; Linzmayer L; Schmid R; Grünberger J
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):307-12. PubMed ID: 1928024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
    Stine SM; Kosten TR
    Am J Drug Alcohol Abuse; 1994 Nov; 20(4):445-58. PubMed ID: 7832179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lamotrigine on naloxone-precipitated opiate withdrawal.
    Rosen MI; Pearsall HR; Kosten TR
    Drug Alcohol Depend; 1998 Oct; 52(2):173-6. PubMed ID: 9800147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification.
    Loimer N; Linzmayer L; Grünberger J
    Drug Alcohol Depend; 1991 Oct; 28(3):265-8. PubMed ID: 1752200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans.
    Stitzer ML; Wright C; Bigelow GE; June HL; Felch LJ
    Drug Alcohol Depend; 1991 Dec; 29(1):39-46. PubMed ID: 1665778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone-induced withdrawal in patients with buprenorphine dependence.
    Nigam AK; Srivastava RP; Saxena S; Chavan BS; Sundaram KR
    Addiction; 1994 Mar; 89(3):317-20. PubMed ID: 8173501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT).
    Krystal JH; Woods SW; Kosten TR; Rosen MI; Seibyl JP; van Dyck CC; Price LH; Zubal IG; Hoffer PB; Charney DS
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):47-63. PubMed ID: 7762544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
    Rosado J; Walsh SL; Bigelow GE; Strain EC
    Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial methadone dose in treating opiate addiction.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of clonidine in opiate withdrawal: a study of 100 patients.
    Gold MS; Kleber HD
    Prog Clin Biol Res; 1981; 71():299-306. PubMed ID: 6276899
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid narcotic detoxification in chronic pain patients treated with auricular electroacupuncture and naloxone.
    Kroening RJ; Oleson TD
    Int J Addict; 1985 Sep; 20(9):1347-60. PubMed ID: 2867052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
    Scherbaum N; Klein S; Kaube H; Kienbaum P; Peters J; Gastpar M
    Pharmacopsychiatry; 1998 Nov; 31(6):205-9. PubMed ID: 9930633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach].
    Presslich O; Loimer N; Aschauer G; Fodor G; Pfersmann D; Müller K; Pakesch G; Lieber A
    Psychiatr Prax; 1989 Sep; 16(5):179-81. PubMed ID: 2798589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.
    Higgins ST; Preston KL; Cone EJ; Henningfield JE; Jaffe JH
    Drug Alcohol Depend; 1992 Apr; 30(1):13-26. PubMed ID: 1591977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute physical dependence in man: repeated naloxone-precipitated withdrawal after a single dose of methadone.
    Wright C; Bigelow GE; Stitzer ML
    NIDA Res Monogr; 1989; 95():395-6. PubMed ID: 2701308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.